-
1
-
-
0018166824
-
Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin
-
Kolhouse JF, Kondo H, Allen NC, Podell E, Allen RH. Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin. N Engl J Med 1978;299:785-92
-
(1978)
N Engl J Med
, vol.299
, pp. 785-792
-
-
Kolhouse, J.F.1
Kondo, H.2
Allen, N.C.3
Podell, E.4
Allen, R.H.5
-
2
-
-
0018073614
-
Evidence that some patients with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum
-
Cooper BA, Whitehead VM. Evidence that some patients with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum. N Engl J Med 1978;299:816-8
-
(1978)
N Engl J Med
, vol.299
, pp. 816-818
-
-
Cooper, B.A.1
Whitehead, V.M.2
-
3
-
-
0033638469
-
Failure of assay to identify low cobalamin concentrations
-
Carmel R, Brar S, Agrawal A, Penha PD. Failure of assay to identify low cobalamin concentrations. Clin Chem 2000;46:2017-8
-
(2000)
Clin Chem
, vol.46
, pp. 2017-2018
-
-
Carmel, R.1
Brar, S.2
Agrawal, A.3
Penha, P.D.4
-
4
-
-
84864193306
-
Failures of cobalamin assays in pernicious anemia
-
Carmel R, Agrawal YP. Failures of cobalamin assays in pernicious anemia. N Engl J Med 2012;367:385-6
-
(2012)
N Engl J Med
, vol.367
, pp. 385-386
-
-
Carmel, R.1
Agrawal, Y.P.2
-
5
-
-
84875862741
-
Diagnosis and management of clinical and subclinical deficiencies: Why controversies persist in the age of sensitive metabolic testing
-
Carmel R. Diagnosis and management of clinical and subclinical deficiencies: Why controversies persist in the age of sensitive metabolic testing. Biochimie 2013;95:1047-55
-
(2013)
Biochimie
, vol.95
, pp. 1047-1055
-
-
Carmel, R.1
-
6
-
-
84886658092
-
The elecsysr vitamin b12 assay is not affected by anti-intrinsic factor antibodies
-
Schilling KA, Weisgigl M. The ElecsysR vitamin B12 assay is not affected by anti-intrinsic factor antibodies. Clin Chem Lab Med 2013;51:e251-e252
-
(2013)
Clin Chem Lab Med
, vol.51
-
-
Schilling, K.A.1
Weisgigl, M.2
-
7
-
-
0034545867
-
Failure of assay to identify low cobalamin concentrations: Representatives of bayer diagnostics respond
-
Emancipator K, Mansbach L, Robert T, Waskiewicz D. Failure of assay to identify low cobalamin concentrations: Representatives of Bayer Diagnostics respond. Clin Chem 2000;46:2018-9
-
(2000)
Clin Chem
, vol.46
, pp. 2018-2019
-
-
Emancipator, K.1
Mansbach, L.2
Robert, T.3
Waskiewicz, D.4
-
8
-
-
29744449111
-
High measured cobalamin (vitamin B12) concentration attributable to an analytical problem in testing serum from a patient with pernicious anemia
-
Vlasveld LT, van't Wout JW, Meeuwissen P, Castel A. High measured cobalamin (vitamin B12) concentration attributable to an analytical problem in testing serum from a patient with pernicious anemia. Clin Chem 2006;52:157-8
-
(2006)
Clin Chem
, vol.52
, pp. 157-158
-
-
Vlasveld, L.T.1
Van't Wout, J.W.2
Meeuwissen, P.3
Castel, A.4
-
9
-
-
79959439256
-
Biomarkers of cobalamin (vitamin B12) status in the epidemiologic setting: A critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II
-
Carmel R. Biomarkers of cobalamin (vitamin B12) status in the epidemiologic setting: A critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 2011;94:348S-58S.
-
(2011)
Am J Clin Nutr
, vol.94
-
-
Carmel, R.1
-
10
-
-
84886696523
-
-
Available From Accessed July 14
-
US Food and Drug Administration. Available from: Http://www. accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail. cfm?mdrfoi-id=2458954. Accessed July 14, 2013
-
(2013)
US Food Drug Administration
-
-
|